The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2024

Filed:

Jun. 27, 2019
Applicant:

Medicago Inc., Quebec, CA;

Inventors:

Pierre-Olivier Lavoie, Quebec, CA;

Aurelien Lorin, Quebec, CA;

Alain Doucet, Quebec, CA;

Marc-Andre D'Aoust, Quebec, CA;

Manon Couture, Quebec, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/11 (2006.01); A61K 38/00 (2006.01); A61K 39/145 (2006.01); A61P 31/16 (2006.01); A61P 37/04 (2006.01); C07K 14/005 (2006.01); C07K 16/10 (2006.01); C12N 7/00 (2006.01); C12N 15/82 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/145 (2013.01); A61P 31/16 (2018.01); A61P 37/04 (2018.01); C07K 14/11 (2013.01); C07K 16/10 (2013.01); C07K 16/1018 (2013.01); C12N 7/00 (2013.01); C12N 15/8257 (2013.01); C12N 15/8258 (2013.01); A61K 38/00 (2013.01); A61K 2039/5258 (2013.01); C12N 2760/16023 (2013.01); C12N 2760/16033 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16123 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16152 (2013.01);
Abstract

Production of modified influenza viral proteins in plants is described. More specifically, producing and increasing influenza virus-like particle (VLP) production in plants, wherein the VLPs comprise the modified influenza viral proteins, such as modified influenza hemagglutinin (HA) is described. The HA protein may comprise an amino acid sequence comprising at least one substitution when compared to a corresponding wildtype amino acid sequence. Further provided are nucleic acids encoding the modified HA protein. Furthermore, methods of producing an influenza virus like particle (VLP) and methods of increasing yield of production of an influenza virus like particle (VLP) in a plant, portion of a plant, or a plant cell, are also provided.


Find Patent Forward Citations

Loading…